• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Life Science Market
Life Science News
Life Science Stocks
  • Life Science Market
  • Life Science News
  • Life Science Stocks

Precision Therapeutics’ Skyline Medical Division Widens Global Reach

Written by Gabrielle Lakusta
|
Jan. 25, 2019 09:40AM PST

Precision Therapeutics (NASDAQ:AIPT) announced that its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY System for automated, direct-to-drain medical fluid disposal, has continued the company’s global expansion by completing a distribution agreement with medical supply distributor, Winner Scientific in Taiwan. As quoted in the press release: Established in 1999 in the North District of Taiwan, Winner …

Precision Therapeutics (NASDAQ:AIPT) announced that its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY System for automated, direct-to-drain medical fluid disposal, has continued the company’s global expansion by completing a distribution agreement with medical supply distributor, Winner Scientific in Taiwan.

As quoted in the press release:

Established in 1999 in the North District of Taiwan, Winner Scientific focuses on the distribution of a variety of product lines for the surgical suite.  The agreement between Winner Scientific and Skyline Medical marks the tenth such agreement with distribution partners throughout the world.  Prior to the Winner Scientific deal, Skyline has secured distribution agreements with Century Scientific & Equipment Company in Kuwait; Device Technologies in Australia, Pacific Islands and New Zealand; MediBridge in Switzerland; MEDIURGE in Pakistan; Prenit World in India; Quadromed in Canada; Sesnebar in Saudi Arabia; Anifro in Bangladesh; and Aras in the United Arab Emirates.  The company also maintains a direct sales representation in Belgium, France and Germany.

The Asia Pacific healthcare market is predicted to continue strong growth, due to expansion in the use of medical services as a result of improved access to universal healthcare across the region, given the incidence of chronic diseases rise in tandem with shifts in lifestyles and an aging population. This is coupled with a larger mix of urban and rural health centers, which results in issues around access and affordability.  Skyline is poised to meet these increasing needs with its efficient STREAMWAY system, which will help meet the increased demand for hygiene and safety requirements in healthcare facilities for both staff and patients.

Click here to read the full press release.

skyline medical nasdaq:aipt
The Conversation (0)

Go Deeper

AI Powered
Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Senior woman doing exercises alongside closeup of DNA.

5 US Longevity and Anti-aging Stocks to Watch

Latest News

Outlook Reports world

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
  • Energy
    • Uranium
    • Oil and Gas
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Industrial Metals
  • Agriculture
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Gaming
    • Cleantech
    • Emerging Tech
Life Science
    • Biotech
    • Cannabis
    • Psychedelics
    • Pharmaceuticals

Featured Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES